Characterization of the Therapeutic Profile of Albiflorin for the Metabolic SyndromeXiu Zhou(Guangdong University of Technology), Ji‐Ming Ye(Garvan Institute of Medical Research)Frontiers in PharmacologyOctober 11, 201910.3389/fphar.2019.01151Cited by 23SaveCiteExport RISWatch citationsRelated PapersMetformin Prevents the Development of Acute Lipid-Induced Insulin Resistance in the Rat Through Altered Hepatic Signaling Mechanisms|Diabetes|2004|79Activation of AMPK by Bitter Melon Triterpenoids Involves CaMKKβ|PLoS ONE|2013|61